Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
August 8, 2008

FDA Taps Simulation Plus’ ADMET Predictor

  • FDA is licensing Simulations Plus’ ADMET Predictor™ software. It will be used by the agency’s Cardiovascular and Renal Products division. The program predicts almost 80 properties of molecules with only their molecular structure as input, including physicochemical, biopharmaceutical, metabolism, toxicity, and some activity properties, reports Ron Creeley, vp of marketing and sales.